Nanotherapy of Glioblastoma—Where Hope Grows
International Journal of Molecular Sciences · 20.02.2025 · 26 (5) · 1814
DOI: 10.3390/ijms26051814 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.02.2025. Verfasst von Jan Grzegorzewski und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Student Scientific Society of Poznan University of Medical Sciences, 60-806 Poznań, Poland. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Nanoparticles, Nanomedicine. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Localization in the central nervous system, diffuse growth, the presence of stem cells, and numerous resistance mechanisms, all make glioblastoma (GBM) an incurable tumor. The standard treatment of GBM consisting of surgery; radio- and chemotherapy with temozolomide provides insufficient therapeutic benefit and needs to be updated with effective modern solutions. One of the most promising and intensively explored therapeutic approaches against GBM is the use of nanotherapy. The first, and so far only, nanoparticle-based therapy approved for GBM treatment is NanoThermTM. It is based on iron oxide nanoparticles and the thermal ablation of the tumor with a magnetic field. Numerous other types of nanotherapies are being evaluated, including polymer and lipid-based nanoformulations, nanodiscs, dendrimers, and metallic, silica, or bioderived nanoparticles, among others. The advantages of these nanoscale drug carriers include improved penetration across the blood–brain barrier, targeted drug delivery, biocompatibility, and lower systemic toxicity, while major problems with their implementation involve scaling up their production and high costs. Nevertheless, taking all the impressive benefits of nanotherapies into consideration, it seems obvious that the combined effort of the scientific world will need to be taken to tackle these challenges and implement these novel therapies into clinics, giving hope that the battle against GBM can finally be won.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Student Scientific Society of Poznan University of Medical Sciences, 60-806 Poznań, Poland.
- Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
ORCID-Profile: Maciej Michalak, Maria Wołoszczuk, Magdalena Bulicz, Aleksandra Majchrzak-Celińska
Zitieren
APA
Grzegorzewski, J., Michalak, M., Wołoszczuk, M., Bulicz, M., & Majchrzak-Celińska, A. (2025). Nanotherapy of Glioblastoma—Where Hope Grows. International Journal of Molecular Sciences, 26(5), 1814. https://doi.org/10.3390/ijms26051814
Vancouver
Grzegorzewski J, Michalak M, Wołoszczuk M, Bulicz M, Majchrzak-Celińska A. Nanotherapy of Glioblastoma—Where Hope Grows. International Journal of Molecular Sciences. 2025;26(5):1814. doi:10.3390/ijms26051814
BibTeX
@article{Grzegorzewski2025,
author = {Grzegorzewski, Jan and Michalak, Maciej and Wołoszczuk, Maria and Bulicz, Magdalena and Majchrzak-Celińska, Aleksandra},
title = {Nanotherapy of Glioblastoma—Where Hope Grows},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {1814},
doi = {10.3390/ijms26051814}
}
EUVIMED